upadacitinib
abbvie
[' upa ']
 presenting late breaking abstract at #acg2022 on upa maintenance therapy for cd (u-endure). both 15 and 30 mg maintenance doses superior to placebo for 52 wk clinical remission &amp; endo response in mod-severe cd 
IBD specialist, Educator & GI Fellowship Program Director @ClevelandClinic| Board of Trustees @AmCollegeGastro| Cleveland sports fan| T/RT = my own